What Mutanex does
Founded in 2024, Mutanex operates in Health Tech offering an AI-powered SaaS platform for personalized precision medicine services. The platform supports rapid and affordable personalized treatments for chronic, genetic, and rare disorders, including cancer, using genetic profiling to eliminate trial-and-error scenarios. With the ability to predict genetic mutations without genetic analysis, Mutanex provides a seamless experience for healthcare providers and patients, delivering treatment insights directly from symptoms, demography, and familial history diagnosis models.
Who runs it
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Mutanex yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.